KOREA PHARMA Co., Ltd. (KOSDAQ: 032300)

KOREA PHARMA Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	174,071	257,943	233,403	529,520	242,129	-
Market Cap Growth	-0.06%	10.51%	-55.92%	118.69%	-	-
Enterprise Value	159,126	248,815	222,946	528,191	235,248	-
Last Close Price	15960.00	23650.00	21352.13	48330.28	22076.70	-
PE Ratio	57.89	3079.40	-207.30	83.47	68.14	-
PS Ratio	2.16	3.10	2.88	6.65	3.39	-
PB Ratio	2.47	3.76	3.90	9.21	5.21	-
P/FCF Ratio	41.73	78.44	40.14	114.12	-85.03	-
P/OCF Ratio	37.37	53.52	28.19	73.62	-277.09	-
EV/Sales Ratio	1.98	2.99	2.75	6.64	3.29	-
EV/EBITDA Ratio	26.21	28.75	26.02	71.46	34.47	-
EV/EBIT Ratio	49.04	42.60	36.03	105.34	51.10	-
EV/FCF Ratio	38.15	75.67	38.34	113.83	-82.61	-
Debt / Equity Ratio	0.41	0.51	0.91	0.93	0.30	0.64
Debt / EBITDA Ratio	3.70	4.03	6.38	7.27	2.04	1.93
Debt / FCF Ratio	6.96	10.60	9.40	11.58	-4.90	2.75
Asset Turnover	0.64	0.66	0.62	0.76	0.97	1.03
Inventory Turnover	2.37	2.59	2.67	2.40	2.30	2.83
Quick Ratio	2.18	1.89	1.14	3.13	1.13	0.81
Current Ratio	3.10	2.56	1.41	3.81	1.79	1.20
Return on Equity (ROE)	4.63%	0.13%	-1.91%	12.25%	8.64%	22.64%
Return on Assets (ROA)	2.50%	2.89%	2.97%	2.97%	3.89%	6.99%
Return on Capital (ROIC)	2.94%	3.35%	3.43%	3.65%	5.53%	10.65%
Earnings Yield	1.73%	0.03%	-0.48%	1.20%	1.30%	-
FCF Yield	2.40%	1.27%	2.49%	0.88%	-1.18%	-
Payout Ratio	18.21%	651.04%	-	8.56%	13.90%	7.95%
Buyback Yield / Dilution	-10.32%	-11.22%	1.22%	-12.80%	-10.95%	-1.93%
Total Shareholder Return	-10.32%	-11.22%	1.22%	-12.80%	-10.95%	-1.93%

Source: S&P Capital IQ. Standard template. Financial Sources.